Several former officials with the U.S. Food and Drugs Administration (FDA) took high-paying jobs with pharmaceutical companies after playing key roles in pushing those Big Pharma firms’ Covid shots through the regulation process.

The “revolving door” was exposed during an investigation by the renowned peer-reviewed British Medical Journal (BMJ).

The discovery is reminiscent of former FDA official Curtis Wright IV.

Wright played a central role in the FDA’s approval of the dangerously addictive opioid OxyContin for Purdue Pharma in 1995.

Shortly after, he left the FDA for a job at Purdue and a massive salary with the company.